Effect of Antimuscarinic Drugs on Cognitive Functions in the Management of Overactive Bladder in Elderly

被引:0
|
作者
Rangganata, Ervandy [1 ]
Widia, Fina [1 ]
Rahardjo, Harrina E. [1 ]
机构
[1] Univ Indonesia, Cipto Mangunkusumo Hosp, Fac Med, Dept Urol, Jl Diponegoro 71, Jakarta 10430, Indonesia
关键词
antimuscarinic drugs; cognitive functions; overactive bladder; mini-mental state examination (MMSE); DOUBLE-BLIND; OLDER; INCONTINENCE; FESOTERODINE; IMIDAFENACIN; TERMINOLOGY; CHLORIDE; THERAPY; SAFETY;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: overactive bladder (OAB) affects 17-41% older adults in community dwelled setting. For several years, antimuscarinics have been validated as the first-line medical treatment for OAB. Despite abundant data obtained from clinical trials provisions the use of antimuscarinics, investigation about the effect of this drug on cognitive function in elderly remains scarce. The objective of this study is to investigate the effect of antimuscarinics therapy on cognitive functions in OAB geriatric patients. Methods: this study design is a .systematic review and meta-analysis. Studies were collected using several search engines; those were PubMed, Science Direct, Cochrane, and EBSCOhost using predetermined MeSH keywords with Boolean operators. Selection of studies was done by three reviewers. Studies which fulfilled the inclusion and exclusion criteria underwent full-text review. For every selected full text, we extracted the following data if available: patients demographics, types of antimuscarinics used, placebo, dose, follow-up period, and Mini-Mental State Examination (MMSE) total score. Results: a total of 8 studies from an initial 146 publications were selected. There were 8 antimuscarinic agents evaluated in the studies, including Oxybutynin, Darifenacin, Tolterodine, Trospium, Imidafenacin, Pmpiverine hydrochloride, Fesoterodine, and Solifenacin. Oxybutynin was shown to have largest effect towards the decline of MMSE score [Mean difference: -2.90; 95% CI: -4.07, -1.73]. Darifenacin and Tolterodine were also shown to be significant in the decline of total MMSE score, although still inferior to Oxybutynin. Conclusion: the use of most antimuscarinics medication has little to no effect towards the cognitive function in the management of overactive bladder in elderly patients. However, Oxybutynin, Darifenacin, and Tolterodine was shown to have significant decrease in cognitive functions, as shown in the decline of total MMSE score.
引用
收藏
页码:255 / 263
页数:9
相关论文
共 50 条
  • [21] Effect of antimuscarinic drugs used for overactive bladder on learning in a rat passive avoidance response test
    Suzuki, Masanori
    Noguchi, Yukiko
    Okutsu, Hiroko
    Ohtake, Akiyoshi
    Sasamata, Masao
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2007, 557 (2-3) : 154 - 158
  • [22] THERAPEUTIC EFFECT CONSOLIDATION IN OVERACTIVE BLADDER TREATMENT IN ELDERLY WOMEN BY THE USE OF INCREASED ANTIMUSCARINIC DOSAGES
    Kosilov, K. V.
    Loparev, S. A.
    Ivanovskaya, M. A.
    Kosilova, L. V.
    SOVREMENNYE TEHNOLOGII V MEDICINE, 2013, 5 (04) : 78 - 82
  • [23] Long-term management of overactive bladder with antimuscarinic agents
    Hampel, Christian
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (05) : 432 - 437
  • [24] Pregnancy among Users of Antimuscarinic Drugs Indicated for the Treatment of Overactive Bladder
    Kremer, Barbara K.
    Quan, Shung-Ping
    Patadia, Vaishali
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S53 - S53
  • [25] ADHERENCE TO ANTIMUSCARINIC MEDICATIONS IN THE ELDERLY NURSING HOME RESIDENTS WITH OVERACTIVE BLADDER
    Sura, S. D.
    Aparasu, R. R.
    VALUE IN HEALTH, 2019, 22 : S386 - S386
  • [26] Effect of antimuscarinic drugs used for overactive bladder on learning and memory in a rat passive avoidance response
    Suzuki, Masanori
    Ohtake, Akiyoshi
    Sasamata, Masao
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 130P - 130P
  • [27] Impact on cognitive function of anticholinergic drugs used for the treatment of overactive bladder in the elderly
    Kerdraon, J.
    Robain, G.
    Jeandel, C.
    Artus, P. Mongiat
    Game, X.
    Fatton, B.
    Scheiber-Nogueira, M. C.
    Vetel, J-M
    Mares, P.
    Petit, A-C
    Amarenco, G.
    PROGRES EN UROLOGIE, 2014, 24 (11): : 672 - 681
  • [28] Overactive bladder -: treatment with antimuscarinic agents
    Höfner, K
    UROLOGE A, 2003, 42 (06): : 793 - +
  • [29] Preferences for antimuscarinic therapy for overactive bladder
    Swinburn, Paul
    Lloyd, Andrew
    Ali, Shehzad
    Hashmi, Noreen
    Newal, David
    Najib, Hiba
    BJU INTERNATIONAL, 2011, 108 (06) : 868 - 873
  • [30] Gender specific pharmacokinetic and pharmacodynamic considerations for antimuscarinic drugs for overactive bladder treatment
    Hartigan, Siobhan M.
    Dmochowski, Roger R.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (02) : 103 - 110